ClinVar Miner

Submissions for variant NM_000257.4(MYH7):c.872C>T (p.Ser291Phe)

dbSNP: rs397516272
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000036008 SCV000059660 uncertain significance not specified 2018-07-10 criteria provided, single submitter clinical testing Variant classified as Uncertain Significance - Favor Pathogenic. The p.Ser291Phe variant in MYH7 has been identified by our laboratory in 2 individuals with HCM . One of these individuals had a second disease-causing variant in MYH7 and pres ented at an earlier age. This variant was absent from large population studies. Computational prediction tools and conservation analysis suggest that the p.Ser2 91Phe variant may impact the protein, though this information is not predictive enough to determine pathogenicity. Additionally, this variant lies in the head r egion of the protein. Missense variants in this region have been reported and st atistically indicated to be more likely to cause disease (Walsh 2016). In summar y, while there is some suspicion for a pathogenic role, the clinical significanc e of the p.Ser291Phe variant is uncertain. ACMG/AMP Criteria applied: PM1; PM2; PP3.
Laboratory of Genetics and Molecular Cardiology, University of São Paulo RCV000201478 SCV000256152 likely pathogenic Hypertrophic cardiomyopathy 1 criteria provided, single submitter clinical testing
Invitae RCV001349519 SCV001543870 uncertain significance Hypertrophic cardiomyopathy 2020-09-17 criteria provided, single submitter clinical testing This variant is not present in population databases (ExAC no frequency). This sequence change replaces serine with phenylalanine at codon 291 of the MYH7 protein (p.Ser291Phe). The serine residue is highly conserved and there is a large physicochemical difference between serine and phenylalanine. This variant has been observed in individual(s) with hypertrophic cardiomyopathy (PMID: 21943931, 27247418, 24093860). ClinVar contains an entry for this variant (Variation ID: 43110). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant is found within a region of MYH7 between codons 181 and 937 that contains the majority of the myosin head domain. Missense variants in this region have been shown to be significantly overrepresented in individuals with hypertrophic cardiomyopathy (PMID: 27532257). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15").
Ambry Genetics RCV002371826 SCV002685817 uncertain significance Cardiovascular phenotype 2021-08-04 criteria provided, single submitter clinical testing The p.S291F variant (also known as c.872C>T), located in coding exon 8 of the MYH7 gene, results from a C to T substitution at nucleotide position 872. The serine at codon 291 is replaced by phenylalanine, an amino acid with highly dissimilar properties. This alteration is located in the myosin head domain, which contains a statistically significant clustering of pathogenic missense variants (Homburger JR et al. Proc Natl Acad Sci U S A, 2016 06;113:6701-6; Walsh R et al. Genet Med, 2017 02;19:192-203; Ambry internal data). This variant has been reported in hypertrophic cardiomyopathy (HCM) clinical and genetic testing cohorts; however, limited details were provided (Lakdawala NK et al. Am J Cardiol, 2011 Dec;108:1606-13; Marsiglia JD et al. Am Heart J, 2013 Oct;166:775-82; Homburger JR et al. Proc Natl Acad Sci U S A, 2016 06;113:6701-6; Walsh R et al. Genet Med, 2017 02;19:192-203). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.